Skip to main content

Immunovant, Inc. (NASDAQ: IMVT) Investor Securities Class Action Lawsuit 02/19/2021

  • If you purchased shares of Immunovant, Inc. (NASDAQ: IMVT), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 15, 2022 - An amended  complaint was filed. February 1, 2022 - A complaint was filed. February 19, 2021 - An investor in shares of Immunovant, Inc. (NASDAQ: IMVT) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation in connection with c...



You must register (for free) or login to view the entire case.